Edition:
United Kingdom

Hisamitsu Pharmaceutical Co Inc (4530.T)

4530.T on Tokyo Stock Exchange

6,170JPY
20 Nov 2017
Change (% chg)

¥-120 (-1.91%)
Prev Close
¥6,290
Open
¥6,260
Day's High
¥6,270
Day's Low
¥6,060
Volume
341,500
Avg. Vol
132,887
52-wk High
¥6,590
52-wk Low
¥4,985

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Underperform -- February 20 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 4.50 4.50 4.50 4.50

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Feb-17 1 144,500.00 144,500.00 144,500.00 --
Year Ending Feb-18 1 147,800.00 147,800.00 147,800.00 156,200.00
Year Ending Feb-19 1 147,200.00 147,200.00 147,200.00 157,300.00
Earnings (per share)
Year Ending Feb-17 2 262.47 266.78 258.17 --
Year Ending Feb-18 2 227.93 239.05 216.82 198.11
Year Ending Feb-19 2 203.79 230.68 176.90 190.02

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending May-16 40,400.00 38,153.00 2,247.00 5.56
Quarter Ending May-15 40,700.00 39,680.00 1,020.00 2.51
Quarter Ending Feb-15 38,060.00 41,803.00 3,743.00 9.83
Quarter Ending Nov-14 44,400.00 37,888.00 6,512.00 14.67
Quarter Ending Aug-14 39,244.00 39,296.00 52.00 0.13

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Feb-17 144,500.00 -- -- -- --
Year Ending Feb-18 147,800.00 147,800.00 149,800.00 148,000.00 156,200.00
Year Ending Feb-19 147,200.00 147,200.00 146,200.00 146,200.00 157,300.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Feb-17 -- -- -- --
Year Ending Feb-18 0 0 0 1
Year Ending Feb-19 0 0 1 0
Earnings